Logo Addus HomeCare Corp.

Addus HomeCare Corp. (ADUS) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
Addus HomeCare Corp. · Health Care · ref. ETF XLV · 70 calls · price $118.01
🔔Price alertsCreate an alert →
What the company does: Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States.

📈 Addus HomeCare Corp. (ADUS) stock price

$118.01+2.3% over range
Aug 28, 25low $88.49 · high $122.75Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
67% recommend buying · 3 analysts
📊 JPI status : Addus HomeCare Corp. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 ADUS price target & analyst consensusprice $118

The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$142+20.3%
Median target · of 3 targets$134+13.5%
Lowest target · 1 firm of 3$96-18.7%
Current price$118.01
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy267%
Hold00%
Sell133%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Addus HomeCare Corp.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on ADUS

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
B of A Securities  100% +16.6% 2
Raymond James  88% +16.7% 8
Sidoti & Co. 67% +29.0% 3
Baird  67% +18.3% 3
Stephens & Co.  62% +9.7% 13
TD Cowen  60% +5.2% 5
Oppenheimer  58% +12.4% 12
RBC Capital  53% +4.6% 17
JMP Securities 20% -7.6% 5
Macquarie  17% -6.1% 6
See the other 1 firms
Barclays  0% -4.0% 2

📊 What $1,000 invested in Addus HomeCare Corp. would be worth › open the full page

In short — $1,000 invested in Addus HomeCare Corp. 10 years ago would be worth $4,661 today, i.e. +17%/yr on average. Best year: 2018 (+95%), worst: 2021 (-20%). Price performance, excluding dividends.

If I'd invested $1,000 in Addus HomeCare Corp.

InvestmentWorth todayGain
1 years ago$866-13%
3 years ago$1,091+9%
5 years ago$927-7%
→ See Addus HomeCare Corp.'s full return history + gain calculator

Return by year (Addus HomeCare Corp.)

YearReturn$1,000 invested at year start
2026 (YTD)+1%$1,010 (+1%)
2025-14%$866 (-13%)
2024+35%$1,169 (+17%)
→ See Addus HomeCare Corp.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Addus HomeCare Corp.

Loading news…

📋 All analyst calls on ADUS

RBC Capital 
Aug 5, 26
▲ Outperform · 🎯$134
Price at call : $118.78 — upside +13%
Today : $118.01 — upside +14%
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Aug 5, 27
Barclays 
Jul 9, 26
▼ Underweight · 🎯$96
Price at call : $109.72 — upside -13%
Today : $118.01 — upside -19%
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Jul 9, 27
Citizens
May 18, 26
▲ Market Outperform · 🎯$142
Price at call : $92.64 — upside +53%
Today : $118.01 — upside +20%
🎯 on ADUS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 18, 27
Barclays 
May 15, 26
▼ Underweight · 🎯$92
Price at call : $92.64 — upside -1%
Today : $118.01 — upside -22%
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 15, 27
Citizens
May 6, 26
▲ Market Outperform · 🎯$142
Price at call : $97.29 — upside +46%
Today : $118.01 — upside +20%
🎯 on ADUS : no call matured yet · 📊 unranked overall
in progress (365j)
matures : May 6, 27
Barclays 
Mar 25, 26
▼ Underweight · 🎯$102
Price at call : $99.32 — upside +3%
Today : $118.01 — upside -14%
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Mar 25, 27
Stephens & Co. 
Feb 25, 26
▲ Overweight · 🎯$135
Price at call : $104.02 — upside +30%
Today : $118.01 — upside +14%
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Feb 25, 27
Barclays 
Feb 24, 26
▼ Underweight · 🎯$112
Price at call : $105.2 — upside +6%
Today : $118.01 — upside -5%
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Feb 24, 27
See the other 62 calls, newest to oldest
BMO Capital 
Nov 13, 25
■ Market Perform neutral · not a buy · 🎯$120
Price at call : $110.78 — gap to target +8%
Today : $118.01 — gap to target +2%
🎯 on ADUS : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Nov 13, 26
RBC Capital 
Nov 7, 25
▲ Outperform · 🎯$139
Price at call : $112.83 — upside +23%
Today : $118.01 — upside +18%
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Nov 7, 26
TD Cowen 
Nov 5, 25
▲ Buy · 🎯$140
Price at call : $114.19 — upside +23%
Today : $118.01 — upside +19%
🎯 on ADUS : 60% (5 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Nov 5, 26
Barclays 
Nov 4, 25
▼ Underweight · 🎯$117
Price at call : $112.22 — upside +4%
Today : $118.01 — upside -1%
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 4, 26
▲ Overweight · 🎯$140
Price at call : $113.1 — upside +24%
Today : $118.01 — upside +19%
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Sep 3, 26
UBS 
Sep 2, 25
▲ Buy · 🎯$145
Price at call : $115.67 — upside +25%
Today : $118.01 — upside +23%
🎯 on ADUS : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Sep 2, 26
RBC Capital 
Aug 22, 25
▲ Outperform · 🎯$134
Price at call : $118.41 — upside +13%
Today : $118.01 — upside +14%
Expected +13% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+2.0%
stock +2% · XLV +26%
matured Aug 22, 26
Barclays 
Aug 19, 25
▼ Underweight · 🎯$109
Price at call : $115.68 — upside -6%
Today : $118.01 — upside -8%
Expected -6% · Actual +4% · Reason (≤ −15%) : ✗ No
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-3.8%
stock +4% · XLV +28%
matured Aug 19, 26
TD Cowen 
Aug 6, 25
▲ Buy · 🎯$139
Price at call : $109.1 — upside +27%
Today : $118.01 — upside +18%
Expected +27% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 60% (5 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
+9.7%
stock +10% · XLV +28%
matured Aug 6, 26
RBC Capital 
Jul 31, 25
▲ Outperform · 🎯$133
Price at call : $104.96 — upside +27%
Today : $118.01 — upside +13%
Expected +27% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+11.3%
stock +11% · XLV +24%
matured Jul 31, 26
JMP Securities
Jul 16, 25
▲ Market Outperform · 🎯$150
Price at call : $109.69 — upside +37%
Today : $118.01 — upside +27%
Expected +37% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 20% (5 calls matureds) · 📊 unranked overall
+4.4%
stock +4% · XLV +21%
matured Jul 16, 26
JMP Securities
Jun 20, 25
▲ Market Outperform · 🎯$150
Price at call : $113.79 — upside +32%
Today : $118.01 — upside +27%
Expected +32% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 20% (5 calls matureds) · 📊 unranked overall
-16.5%
stock -16% · XLV +13%
matured Jun 20, 26
Macquarie 
Jun 10, 25
▲ Outperform · 🎯$133
Price at call : $112.69 — upside +18%
Today : $118.01 — upside +13%
Expected +18% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 17% (6 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
-17.4%
stock -17% · XLV +14%
matured Jun 10, 26
Macquarie 
May 8, 25
▲ Outperform · 🎯$133
Price at call : $110.7 — upside +20%
Today : $118.01 — upside +13%
Expected +20% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 17% (6 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
-10.1%
stock -10% · XLV +7%
matured May 8, 26
JMP Securities
Apr 22, 25
▲ Market Outperform · 🎯$150
Price at call : $98.04 — upside +53%
Today : $118.01 — upside +27%
Expected +53% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 20% (5 calls matureds) · 📊 unranked overall
-3.3%
stock -3% · XLV +8%
matured Apr 22, 26
JMP Securities
Apr 10, 25
▲ Market Outperform · 🎯$150
Price at call : $101.77 — upside +47%
Today : $118.01 — upside +27%
Expected +47% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 20% (5 calls matureds) · 📊 unranked overall
-9.4%
stock -9% · XLV +9%
matured Apr 10, 26
Stephens & Co. 
Mar 12, 25
▲ Overweight · 🎯$142
Price at call : $90.78 — upside +56%
Today : $118.01 — upside +20%
Expected +56% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+11.6%
stock +12% · XLV +4%
matured Mar 12, 26
Macquarie 
Feb 27, 25
▲ Outperform · 🎯$129
Price at call : $95.77 — upside +35%
Today : $118.01 — upside +9%
Expected +35% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 17% (6 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
+9.9%
stock +10% · XLV +6%
matured Feb 27, 26
Stephens & Co. 
Feb 26, 25
▲ Overweight · 🎯$142
Price at call : $95.68 — upside +48%
Today : $118.01 — upside +20%
Expected +48% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+8.7%
stock +9% · XLV +6%
matured Feb 26, 26
Oppenheimer 
Jan 24, 25
▲ Outperform · 🎯$150
Price at call : $132.81 — upside +13%
Today : $118.01 — upside +27%
Expected +13% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-16.9%
stock -17% · XLV +7%
matured Jan 24, 26
JMP Securities
Dec 16, 24
▲ Market Outperform · 🎯$150
Price at call : $130.41 — upside +15%
Today : $118.01 — upside +27%
Expected +15% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 20% (5 calls matureds) · 📊 unranked overall
-13.0%
stock -13% · XLV +11%
matured Dec 16, 25
RBC Capital 
Nov 14, 24
▲ Outperform · 🎯$136
Price at call : $119.78 — upside +14%
Today : $118.01 — upside +15%
Expected +14% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-10.0%
stock -10% · XLV +7%
matured Nov 14, 25
▲ Overweight · 🎯$145
Price at call : $129.08 — upside +12%
Today : $118.01 — upside +23%
Expected +12% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-12.4%
stock -12% · XLV -2%
matured Nov 6, 25
RBC Capital 
Nov 6, 24
▲ Outperform · 🎯$136
Price at call : $129.08 — upside +5%
Today : $118.01 — upside +15%
Expected +5% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-12.4%
stock -12% · XLV -2%
matured Nov 6, 25
Macquarie 
Nov 4, 24
▲ Outperform · 🎯$139
Price at call : $124.17 — upside +12%
Today : $118.01 — upside +18%
Expected +12% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 17% (6 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
-3.5%
stock -3% · XLV -1%
matured Nov 4, 25
Macquarie 
Oct 11, 24
▲ Outperform · 🎯$139
Price at call : $131.81 — upside +5%
Today : $118.01 — upside +18%
Expected +5% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 17% (6 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
-14.6%
stock -15% · XLV -8%
matured Oct 11, 25
Keybanc 
Oct 11, 24
▲ Overweight · 🎯$150
Price at call : $131.81 — upside +14%
Today : $118.01 — upside +27%
Expected +14% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 0% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
-14.6%
stock -15% · XLV -8%
matured Oct 11, 25
Oppenheimer 
Sep 23, 24
▲ Outperform · 🎯$145
Price at call : $133.29 — upside +9%
Today : $118.01 — upside +23%
Expected +9% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-12.3%
stock -12% · XLV -11%
matured Sep 23, 25
RBC Capital 
Sep 3, 24
▲ Outperform · 🎯$141
Price at call : $130.58 — upside +8%
Today : $118.01 — upside +19%
Expected +8% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-14.3%
stock -14% · XLV -12%
matured Sep 3, 25
RBC Capital 
Aug 8, 24
▲ Outperform · 🎯$141
Price at call : $124.63 — upside +13%
Today : $118.01 — upside +19%
Expected +13% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-10.2%
stock -10% · XLV -13%
matured Aug 8, 25
TD Cowen 
Aug 8, 24
▲ Buy · 🎯$137
Price at call : $124.63 — upside +10%
Today : $118.01 — upside +16%
Expected +10% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 60% (5 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
-10.2%
stock -10% · XLV -13%
matured Aug 8, 25
▲ Overweight · 🎯$143
Price at call : $124.47 — upside +15%
Today : $118.01 — upside +21%
Expected +15% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-11.5%
stock -11% · XLV -13%
matured Aug 7, 25
Oppenheimer 
Aug 7, 24
▲ Outperform · 🎯$140
Price at call : $122.22 — upside +15%
Today : $118.01 — upside +19%
Expected +15% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-10.7%
stock -11% · XLV -12%
matured Aug 7, 25
▲ Overweight · 🎯$138
Price at call : $122.22 — upside +13%
Today : $118.01 — upside +17%
Expected +13% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-10.7%
stock -11% · XLV -12%
matured Aug 6, 25
Macquarie 
Jun 28, 24
▲ Outperform · 🎯$136
Price at call : $116.11 — upside +17%
Today : $118.01 — upside +15%
Expected +17% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 17% (6 calls matureds) · 📊 on Health : 40% · +4.7% (10 calls)
-0.8%
stock -1% · XLV -8%
matured Jun 28, 25
TD Cowen 
Jun 18, 24
▲ Buy · 🎯$128
Price at call : $116.9 — upside +9%
Today : $118.01 — upside +8%
Expected +9% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 60% (5 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
-2.7%
stock -3% · XLV -9%
matured Jun 18, 25
Oppenheimer 
Jun 7, 24
▲ Outperform · 🎯$130
Price at call : $114.54 — upside +13%
Today : $118.01 — upside +10%
Expected +13% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+1.8%
stock +2% · XLV -8%
matured Jun 7, 25
Stephens & Co. 
May 31, 24
▲ Overweight · 🎯$128
Price at call : $113.47 — upside +13%
Today : $118.01 — upside +8%
Expected +13% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-2.0%
stock -2% · XLV -8%
matured May 31, 25
TD Cowen 
May 9, 24
▲ Buy · 🎯$119
Price at call : $109.26 — upside +9%
Today : $118.01 — upside +1%
Expected +9% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 60% (5 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
+1.2%
stock +1% · XLV -5%
matured May 9, 25
▲ Overweight · 🎯$115
Price at call : $107.09 — upside +7%
Today : $118.01 — upside -3%
Expected +7% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+3.4%
stock +3% · XLV -6%
matured May 7, 25
▲ Buy · 🎯$118
Price at call : $104.59 — upside +13%
Today : $118.01 — upside -0%
Expected +13% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 100% (1 call matured) · 📊 on Health : 51.3% · +3.0% (152 calls)
+7.4%
stock +7% · XLV -5%
matured May 7, 25
Barclays 
Apr 23, 24
▼ Underweight · 🎯$83
Price at call : $95.5 — upside -13%
Today : $118.01 — upside -30%
Expected -13% · Actual +4% · Reason (≤ −15%) : ✗ No
🎯 on ADUS : 0% (2 calls matureds) · 📊 on Health : 37.3% · -8.4% (150 calls)
-4.2%
stock +4% · XLV -2%
matured Apr 23, 25
Oppenheimer 
Mar 26, 24
▲ Outperform · 🎯$118
Price at call : $103.74 — upside +14%
Today : $118.01 — upside -0%
Expected +14% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-5.7%
stock -6% · XLV -2%
matured Mar 26, 25
RBC Capital 
Feb 29, 24
▲ Outperform · 🎯$102
Price at call : $93.86 — upside +9%
Today : $118.01 — upside -14%
Expected +9% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+1.2%
stock +1% · XLV +2%
matured Feb 28, 25
Oppenheimer 
Jan 17, 24
▲ Outperform · 🎯$118
Price at call : $90.54 — upside +30%
Today : $118.01 — upside -0%
Expected +30% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+47.9%
stock +48% · XLV +1%
matured Jan 16, 25
TD Cowen 
Dec 12, 23
▲ Outperform · 🎯$105
Price at call : $94.41 — upside +11%
Today : $118.01 — upside -11%
Expected +11% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 60% (5 calls matureds) · 📊 on Health : 55.3% · -0.8% (38 calls)
+28.1%
stock +28% · XLV +6%
matured Dec 11, 24
RBC Capital 
Nov 1, 23
▲ Outperform · 🎯$102
Price at call : $82.09 — upside +24%
Today : $118.01 — upside -14%
Expected +24% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+53.8%
stock +54% · XLV +17%
matured Oct 31, 24
▲ Overweight · 🎯$105
Price at call : $82.09 — upside +28%
Today : $118.01 — upside -11%
Expected +28% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+53.8%
stock +54% · XLV +17%
matured Oct 31, 24
Oppenheimer 
Aug 2, 23
▲ Outperform · 🎯$118
Price at call : $95.52 — upside +24%
Today : $118.01 — upside -0%
Expected +24% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+27.7%
stock +28% · XLV +13%
matured Aug 1, 24
▲ Overweight · 🎯$110
Price at call : $95.52 — upside +15%
Today : $118.01 — upside -7%
Expected +15% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+27.7%
stock +28% · XLV +13%
matured Aug 1, 24
▲ Overweight · 🎯$100
Price at call : $95.52 — upside +5%
Today : $118.01 — upside -15%
Expected +5% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+27.7%
stock +28% · XLV +13%
matured Jul 31, 24
Oppenheimer 
Jun 29, 23
▲ Outperform · 🎯$118
Price at call : $92.7 — upside +27%
Today : $118.01 — upside -0%
Expected +27% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+25.3%
stock +25% · XLV +9%
matured Jun 28, 24
Oppenheimer 
May 26, 23
▲ Outperform · 🎯$118
Price at call : $88.37 — upside +34%
Today : $118.01 — upside -0%
Expected +34% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+26.5%
stock +27% · XLV +13%
matured May 25, 24
RBC Capital 
May 3, 23
▲ Outperform · 🎯$109
Price at call : $80.75 — upside +35%
Today : $118.01 — upside -8%
Expected +35% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
+21.6%
stock +22% · XLV +6%
matured May 2, 24
Oppenheimer 
May 3, 23
▲ Outperform · 🎯$118
Price at call : $83.51 — upside +41%
Today : $118.01 — upside -0%
Expected +41% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+17.8%
stock +18% · XLV +5%
matured May 2, 24
▲ Overweight · 🎯$123
Price at call : $86.5 — upside +42%
Today : $118.01 — upside +4%
Expected +42% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+13.8%
stock +14% · XLV +5%
matured May 1, 24
▲ Overweight · 🎯$123
Price at call : $108.19 — upside +14%
Today : $118.01 — upside +4%
Expected +14% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-5.6%
stock -6% · XLV +7%
matured Apr 4, 24
RBC Capital 
Mar 6, 23
▲ Outperform · 🎯$123
Price at call : $103.63 — upside +19%
Today : $118.01 — upside +4%
Expected +19% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-5.7%
stock -6% · XLV +12%
matured Mar 5, 24
RBC Capital 
Nov 2, 22
▲ Outperform · 🎯$121
Price at call : $107.8 — upside +12%
Today : $118.01 — upside +3%
Expected +12% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-23.8%
stock -24% · XLV -3%
matured Nov 2, 23
RBC Capital 
Aug 3, 22
▲ Outperform · 🎯$110
Price at call : $95.18 — upside +16%
Today : $118.01 — upside -7%
Expected +16% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 42% (12 calls matureds) · 📊 on Health : 30.7% · -10.7% (166 calls)
-0.5%
stock -0% · XLV +1%
matured Aug 3, 23
Oppenheimer 
Aug 3, 22
▲ Outperform · 🎯$130
Price at call : $95.18 — upside +37%
Today : $118.01 — upside +10%
Expected +37% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
-0.5%
stock -0% · XLV +1%
matured Aug 3, 23
Oppenheimer 
Sep 30, 14
▲ Outperform · 🎯$24
Price at call : $20.15 — upside +19%
Today : $118.01 — upside -80%
Expected +19% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on ADUS : 58% (12 calls matureds) · 📊 on Health : 47.3% · +6.3% (93 calls)
+48.4%
stock +48% · XLV +6%
matured Sep 30, 15

Frequently asked questions

Should I buy Addus HomeCare Corp. stock?

This isn't buy advice. For Addus HomeCare Corp., the analyst consensus is "Hold", with an average price target of $134 (+14% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Addus HomeCare Corp.). We show the numbers — you decide.

Is it too late to buy Addus HomeCare Corp.? How high can it go?

The most bullish analyst target on Addus HomeCare Corp. is $142 (+20% above today's price); the average is $134. That's the upside they see. Check how reliable those analysts have actually been on Addus HomeCare Corp. on our site before trusting it.

Is Addus HomeCare Corp. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Addus HomeCare Corp., the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.

What has Addus HomeCare Corp.'s past performance been?

Historical returns and a "how much if I had invested" calculator: ADUS performance & returns.

What is the best month to buy ADUS?

The 12 months ranked by the stock's past returns: best & worst month to buy ADUS.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)